Lv1
46 积分 2024-04-30 加入
Breathing new life into T-cell receptor-engineered T-cell therapy in solid tumors: enhancing strategies to expand the universality of precision therapy
1天前
已关闭
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
1个月前
已完结
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
1个月前
已完结
Correspondence on: ‘CD19-CAR T-cell therapy induces deep tissue depletion of B cells’ by Tur et al
1个月前
已关闭
CD19-CAR T-cell therapy induces deep tissue depletion of B cells
1个月前
已完结
Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial
2个月前
已完结
B cell depletion in autoimmune disease: in vivo CAR-T or T cell engagers?
2个月前
已完结
B-cell depletion in autoimmune diseases
2个月前
已完结
Cell Therapies and Bispecific Engagers: Redefining Strategies Against Checkpoint Resistance
2个月前
已完结
The evolving regulatory system of advanced therapy medicinal products in China: a documentary analysis using the World Health Organization Global Benchmarking Tool standards
2个月前
已完结
皖公网安备34019202002308
